Conventional and Complementary Therapies: A Tale of Two Research Standards?
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 20, 2010
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Acupuncture Therapy (MeSH)
- Antimetabolites, Antineoplastic (MeSH)
- Antineoplastic Combined Chemotherapy Protocols (MeSH)
- Clinical Trials as Topic (MeSH)
- Complementary Therapies (MeSH)
- Cyclohexanols (MeSH)
- Deoxycytidine (MeSH)
- Dietary Supplements (MeSH)
- Evidence-Based Medicine (MeSH)
- Gemcitabine (MeSH)
- Hot Flashes (MeSH)
- Humans (MeSH)
- Neoplasms (MeSH)
- Oncology & Carcinogenesis (Science Metrix)
- Peptide Hydrolases (MeSH)
- Risk Assessment (MeSH)
- Time Factors (MeSH)
- Treatment Outcome (MeSH)
- Venlafaxine Hydrochloride (MeSH)
published in
- Journal of Clinical Oncology Journal